Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cybin Inc. (HELP.NE)

Cybin Inc. (HELP.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 379,268
  • Shares Outstanding, K 49,894
  • Annual Sales, $ 0 K
  • Annual Income, $ -79,055 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.9000 +28.31%
on 03/31/26
7.7500 -2.32%
on 04/14/26
+1.1700 (+18.28%)
since 03/13/26
3-Month
5.9000 +28.31%
on 03/31/26
11.6100 -34.80%
on 03/04/26
-3.4200 (-31.12%)
since 01/15/26

Most Recent Stories

More News
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market

EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END

HELP : 5.50 (+0.73%)
AZN : 201.21 (-1.55%)
JNJ : 238.67 (-0.60%)
HELP.NE : 7.5700 (-0.39%)
ABBV : 208.42 (-0.05%)
TAK : 17.85 (unch)

Business Summary

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression,...

See More

Key Turning Points

3rd Resistance Point 7.7433
2nd Resistance Point 7.6767
1st Resistance Point 7.6233
Last Price 7.5700
1st Support Level 7.5033
2nd Support Level 7.4367
3rd Support Level 7.3833

See More

52-Week High 12.1200
Fibonacci 61.8% 9.7440
Fibonacci 50% 9.0100
Fibonacci 38.2% 8.2760
Last Price 7.5700
52-Week Low 5.9000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.